COMMUNIQUÉS West-GlobeNewswire

Oxford Immunotec to Present at the 36th Annual J.P. Morgan Healthcare Conference

03/01/2018 - 15:25

OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, [...]

$600,000 California Purchase Order Fulfilled by Wildflower

03/01/2018 - 15:15

VANCOUVER, British Columbia, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (the “Company”) announced today the fulfillment of its initial purchase order announced December 14, 2017, through its [...]

Canada House Wellness Group Announces its 2018 Executive Team

03/01/2018 - 15:06

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased [...]

2nd Annual Medical Capital Innovation Competition to Take Place April 23-24, 2018

03/01/2018 - 15:00

CLEVELAND, Jan. 03, 2018 (GLOBE NEWSWIRE) -- BioEnterprise, in partnership with the Global Center for Health Innovation (Global Center), Cuyahoga County, and Healthcare Information and Management Systems Society (HIMSS [...]

MRI Interventions ClearPoint® Neuro Navigation System Utilized for the First Time in Minnesota

03/01/2018 - 15:00

IRVINE, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on Magnetic Resonance Imaging (MRI)-Guided Neurosurgical procedures, announced [...]

Sensoria Health and Optima Join Forces to Create Smart Diabetic Footwear: Motus Smart, Powered by Sensoria

03/01/2018 - 15:00

LAS VEGAS, Jan. 03, 2018 (GLOBE NEWSWIRE) -- At CES 2018, Sensoria® Health and Optima Molliter will announce a partnership to create the first smart diabetic footwear product that will monitor a patient's compliance to [...]

CURE Pharmaceutical to Present at 2018 Biotech Showcase

03/01/2018 - 15:00

OXNARD, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, will be a presenting company at the 2018 Biotech Showcase in San [...]

INSYS Therapeutics to Present at J.P. Morgan Healthcare Conference

03/01/2018 - 15:00

PHOENIX, Jan. 03, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), announced today that Saeed Motahari, president and chief executive officer, and Andrew Long, chief financial officer, will present at [...]

OrthoPediatrics Corp. Expands PediPlates® Franchise with Titanium System

03/01/2018 - 15:00

WARSAW, Ind., Jan. 03, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the launch of Titanium [...]

Editas Medicine to Present at the 36th Annual J.P. Morgan Healthcare Conference

03/01/2018 - 14:57

CAMBRIDGE, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced that it will present a company overview followed by a question and answer [...]

CV Sciences, Inc. to Present at the Biotech Showcase™ 2018

03/01/2018 - 14:45

LAS VEGAS, Jan. 03, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. , (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent supplier and manufacturer of hemp-derived phytocannabinoids, including CBD oil and [...]

Spark Therapeutics Announces First-of-their-kind Programs to Improve Patient Access to LUXTURNA™ (voretigene neparvovec-rzyl), a One-time Gene Therapy Treatment

03/01/2018 - 14:30

Company offers outcomes-based rebates and an innovative contracting model that support patient access in the U.S. while aiming to reduce risk and financial burden for payers and treatment centers Harvard Pilgrim and [...]

Bellerophon Announces First Patient Enrolled in Phase 2b Study Evaluating INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

03/01/2018 - 14:30

WARREN, N.J., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ), a clinical-stage biotherapeutics company, today announced that the first patient has been randomized into a Phase 2b study [...]

Agritek Holdings, Inc. Announces Availability Of New Microdose Strips Oral Tabs For New California Recreational And Medical Cannabis Markets For 2018

03/01/2018 - 14:30

LOS ANGELES, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]

ChemoCentryx to Present at the 36th Annual J.P. Morgan Healthcare Conference

03/01/2018 - 14:30

MOUNTAIN VIEW, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer, today [...]

Acer Therapeutics to Present at the Biotech Showcase™ 2018 Conference

03/01/2018 - 14:30

NEWTON, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra- [...]

Anthera Pharmaceuticals Announces Appointment of Patrick Murphy as Senior Vice President, Manufacturing

03/01/2018 - 14:30

HAYWARD, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) today announced the appointment of Patrick Murphy as Senior Vice President, Manufacturing. Patrick brings over 35 years of [...]

Zosano Pharma Announces Notice of Allowance for a U.S. Patent Application Covering M207 as an Acute Treatment for Migraine

03/01/2018 - 14:30

FREMONT, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corp. (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical stage biopharmaceutical company focused on providing rapid systemic administration of [...]

Avinger Announces Treatment of First Patients Globally With Next Generation Pantheris

03/01/2018 - 14:30

REDWOOD CITY, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that Arne Schwindt, M.D., a vascular [...]